17-45115219-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_133373.5(PLCD3):c.1586C>T(p.Ser529Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000214 in 1,572,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00023 ( 0 hom. )
Consequence
PLCD3
NM_133373.5 missense
NM_133373.5 missense
Scores
7
7
1
Clinical Significance
Conservation
PhyloP100: 6.50
Genes affected
PLCD3 (HGNC:9061): (phospholipase C delta 3) This gene encodes a member of the phospholipase C family, which catalyze the hydrolysis of phosphatidylinositol 4,5-bisphosphate to generate the second messengers diacylglycerol and inositol 1,4,5-trisphosphate (IP3). Diacylglycerol and IP3 mediate a variety of cellular responses to extracellular stimuli by inducing protein kinase C and increasing cytosolic Ca(2+) concentrations. This enzyme localizes to the plasma membrane and requires calcium for activation. Its activity is inhibited by spermine, sphingosine, and several phospholipids. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.819
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLCD3 | NM_133373.5 | c.1586C>T | p.Ser529Leu | missense_variant | 10/15 | ENST00000619929.5 | NP_588614.1 | |
PLCD3 | XM_024450554.2 | c.1586C>T | p.Ser529Leu | missense_variant | 10/15 | XP_024306322.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLCD3 | ENST00000619929.5 | c.1586C>T | p.Ser529Leu | missense_variant | 10/15 | 1 | NM_133373.5 | ENSP00000479636.1 | ||
PLCD3 | ENST00000611986.1 | n.349C>T | non_coding_transcript_exon_variant | 3/4 | 5 | |||||
PLCD3 | ENST00000615898.4 | n.61C>T | non_coding_transcript_exon_variant | 2/4 | 3 | |||||
PLCD3 | ENST00000618022.4 | n.125C>T | non_coding_transcript_exon_variant | 1/3 | 4 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152130Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
16
AN:
152130
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000104 AC: 20AN: 191438Hom.: 0 AF XY: 0.0000776 AC XY: 8AN XY: 103096
GnomAD3 exomes
AF:
AC:
20
AN:
191438
Hom.:
AF XY:
AC XY:
8
AN XY:
103096
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000225 AC: 320AN: 1420670Hom.: 0 Cov.: 32 AF XY: 0.000221 AC XY: 155AN XY: 702488
GnomAD4 exome
AF:
AC:
320
AN:
1420670
Hom.:
Cov.:
32
AF XY:
AC XY:
155
AN XY:
702488
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000105 AC: 16AN: 152130Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74306
GnomAD4 genome
AF:
AC:
16
AN:
152130
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
74306
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
6
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2023 | The c.1586C>T (p.S529L) alteration is located in exon 10 (coding exon 10) of the PLCD3 gene. This alteration results from a C to T substitution at nucleotide position 1586, causing the serine (S) at amino acid position 529 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D
MetaSVM
Uncertain
T
PrimateAI
Uncertain
T
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at